Identification of madangamine A as a novel lysosomotropic agent to inhibit autophagy

Bioorg Med Chem. 2021 Mar 15:34:116041. doi: 10.1016/j.bmc.2021.116041. Epub 2021 Jan 27.

Abstract

Madangamines are marine natural products isolated from Xestospongia ingens, and madangamine A-E with a different D-ring structure have been reported. We have reported that madangamine A has strong anti-proliferative activity against various human cancer cell lines. In this study, to clarify the anti-proliferative activity of madangamine A, we searched for molecular target of the madangamine A in human cells. Treatment with madangamine A increased the levels of LC3-II and p62, autophagy-related proteins, concomitant with growth inhibition. Moreover, madangamine A resulted in lysosome enlargement and increase in lysosomal pH, which are same phenomena observed in chloroquine-treated cells. These results suggest that madangamine A is a novel lysosome inhibitor, and the anti-proliferative activity of madangamine A is due to the inhibition of lysosome function.

Keywords: Antiproliferative activity; Autophagy; Lysosomotropic agent; Madangamine; Marine natural product.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autophagy / drug effects*
  • Biological Products
  • Cell Line, Tumor
  • Gene Expression Regulation, Neoplastic / drug effects
  • Heterocyclic Compounds, 4 or More Rings / chemistry
  • Heterocyclic Compounds, 4 or More Rings / pharmacology*
  • Humans
  • Microtubule-Associated Proteins / genetics
  • Microtubule-Associated Proteins / metabolism
  • Molecular Structure
  • Porifera / chemistry*
  • Up-Regulation

Substances

  • Biological Products
  • Heterocyclic Compounds, 4 or More Rings
  • MAP1LC3B protein, human
  • Microtubule-Associated Proteins
  • madangamine A